Gossamer Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Gossamer Bio and other ETFs, options, and stocks.About GOSS
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions.
CEOFaheem Hasnain
CEOFaheem Hasnain
Employees145
Employees145
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2015
Founded2015
Employees145
Employees145
GOSS Key Statistics
Market cap768.43M
Market cap768.43M
Price-Earnings ratio-4.98
Price-Earnings ratio-4.98
Dividend yield—
Dividend yield—
Average volume2.87M
Average volume2.87M
High today$3.44
High today$3.44
Low today$3.30
Low today$3.30
Open price$3.41
Open price$3.41
Volume2.19M
Volume2.19M
52 Week high$3.60
52 Week high$3.60
52 Week low$0.6666
52 Week low$0.6666
Stock Snapshot
With a market cap of 768.43M, Gossamer Bio(GOSS) trades at $3.37. The stock has a price-to-earnings ratio of -4.98.
As of 2025-12-04, Gossamer Bio(GOSS) stock has fluctuated between $3.30 and $3.44. The current price stands at $3.37, placing the stock +2.1% above today's low and -2.0% off the high.
Gossamer Bio(GOSS) shares are trading with a volume of 2.19M, against a daily average of 2.87M.
In the last year, Gossamer Bio(GOSS) shares hit a 52-week high of $3.60 and a 52-week low of $0.67.
In the last year, Gossamer Bio(GOSS) shares hit a 52-week high of $3.60 and a 52-week low of $0.67.
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own GOSS. This list is generated using Robinhood data, and it’s not a recommendation.